1 Min Read
April 4 (Reuters) - Tonix Pharmaceuticals Holding Corp :
* DESIGNATED PTSD PROGRAM AT THE MICROCAP CONFERENCE IN NEW YORK
* INTERIM RESULTS OF HONOR STUDY EXPECTED IN Q3 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.